Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin paste versus nystatin for denture stomatitis
IRCT20141130020158N3Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of atorvastatin and nystatin in denture stomatitis (DS) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Lesion size decreases and Severity of denture stomatitis. Started Aug 2022; status: completed.
02
Drugs
atorvastatinnystatin
03
Conditions
denture stomatitis (DS)
Beyond the preview
Go deeper on IRCT20141130020158N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141130020158N3.